Learn More
Medchemexpress LLC Enozertinib hemihydrate | 2489185-38-6 | 100.0% | 669.77 | C35H42F2N8O3·1/2H2O | 10 MG

Supplier: Medchemexpress LLC HY172429A10MG
Enozertinib hemihydrate is a small-molecule, brain-penetrant inhibitor of EGFR and HER2 supplied as a hemihydrate for research use. It is orally bioavailable and exhibits antineoplastic activity against EGFR-altered tumors, including exon 20 insertions; intended for laboratory research and not for human use.
- Hemihydrate form for consistent handling and stability.
- High purity suitable for biochemical and cellular assays.
- Brain-penetrant and orally bioavailable properties.
- Targets EGFR and HER2 alterations, including exon 20 insertions.
- Supplied in small-mass packs for preclinical research.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.